1. Home
  2. AAPG vs SNDR Comparison

AAPG vs SNDR Comparison

Compare AAPG & SNDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • SNDR
  • Stock Information
  • Founded
  • AAPG 2009
  • SNDR 1935
  • Country
  • AAPG China
  • SNDR United States
  • Employees
  • AAPG N/A
  • SNDR N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • SNDR Trucking Freight/Courier Services
  • Sector
  • AAPG Health Care
  • SNDR Industrials
  • Exchange
  • AAPG Nasdaq
  • SNDR Nasdaq
  • Market Cap
  • AAPG 3.6B
  • SNDR 4.0B
  • IPO Year
  • AAPG 2025
  • SNDR 2017
  • Fundamental
  • Price
  • AAPG $33.87
  • SNDR $21.39
  • Analyst Decision
  • AAPG Strong Buy
  • SNDR Buy
  • Analyst Count
  • AAPG 3
  • SNDR 15
  • Target Price
  • AAPG $49.00
  • SNDR $26.27
  • AVG Volume (30 Days)
  • AAPG 8.0K
  • SNDR 1.0M
  • Earning Date
  • AAPG 11-19-2025
  • SNDR 10-30-2025
  • Dividend Yield
  • AAPG N/A
  • SNDR 1.75%
  • EPS Growth
  • AAPG N/A
  • SNDR 0.60
  • EPS
  • AAPG N/A
  • SNDR 0.64
  • Revenue
  • AAPG $54,524,554.00
  • SNDR $5,613,800,000.00
  • Revenue This Year
  • AAPG N/A
  • SNDR $10.27
  • Revenue Next Year
  • AAPG $368.64
  • SNDR $4.78
  • P/E Ratio
  • AAPG N/A
  • SNDR $33.84
  • Revenue Growth
  • AAPG N/A
  • SNDR 5.46
  • 52 Week Low
  • AAPG $16.50
  • SNDR $20.11
  • 52 Week High
  • AAPG $48.45
  • SNDR $33.90
  • Technical
  • Relative Strength Index (RSI)
  • AAPG 47.99
  • SNDR 42.21
  • Support Level
  • AAPG $30.93
  • SNDR $21.83
  • Resistance Level
  • AAPG $34.31
  • SNDR $22.57
  • Average True Range (ATR)
  • AAPG 0.81
  • SNDR 0.73
  • MACD
  • AAPG 0.26
  • SNDR -0.04
  • Stochastic Oscillator
  • AAPG 85.99
  • SNDR 42.16

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About SNDR Schneider National Inc.

Schneider National Inc is a provider of surface transportation and logistics solutions in North America. The Company offers truckload, intermodal, and logistics services to a diverse customer base throughout the continental United States, Canada, and Mexico. The company's segments include Truckload; Intermodal; Logistics and other. It generates maximum revenue from the Truckload segment.

Share on Social Networks: